-
1
BETTER OUTCOME OF HIGH-DOSE CEFTAZIDIME IN HEMATO – ONCOLOGICAL PATIENTS WITH INFECTIONS CAUSED BY EXTENSIVELY DRUG-RESISTANT PSEUDOMONAS AERUGINOSA
Published 2022-12-01Subjects: “…ceftazidime…”
Get full text
Article -
2
Ceftazidime–avibactam for the Treatment of Intra-abdominal Sepsis and Urosepsis: A Retrospective Hospital-based Study in India
Published 2024-12-01Subjects: “…ceftazidime–avibactam…”
Get full text
Article -
3
Ceftazidime-Avibactam Versus Colistin for the Treatment of Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Infections: A Multicenter Cohort Study
Published 2025-01-01Subjects: Get full text
Article -
4
Efficacy of ceftazidime-avibactam with or without polymyxin for carbapenem-resistant Klebsiella pneumoniae infections after initial treatment with polymyxin
Published 2025-01-01Subjects: “…ceftazidime-avibactam…”
Get full text
Article -
5
-
6
Adaptation of an in vitro one-compartment pharmacodynamic chemostat for testing efficacy of ceftazidime against Burkholderia pseudomallei outside a BSL3 facility
Published 2025-06-01Subjects: “…In vitro one-compartment chemostat for evaluating ceftazidime PK/PD against B. pseudomallei…”
Get full text
Article -
7
A targeted and synergetic nano-delivery system against Pseudomonas aeruginosa infection for promoting wound healing
Published 2025-04-01Subjects: Get full text
Article -
8
Investigating Gram-negative bacilli isolates’ sensitivity to ceftazidime/avibactam
Published 2025-01-01Subjects: Get full text
Article -
9
Effectiveness of antimicrobial agent combinations against carbapenem-producing Klebsiella pneumoniae with KPC variants in China
Published 2025-01-01Subjects: Get full text
Article